A Medical Device Daily

Boston Scientific (Natick, Massachusetts) reported the pricing of a public offering of $2 billion aggregate principal amount of its senior notes under its shelf registration statement.

The offering consists of $850 million of 4.50% notes due January 2015, $850 million of 6% notes due January 2020 and $300 million of 7.375% notes due January 2040.

The company expects the offering to close today, and said it plans to use the net proceeds for general corporate purposes, including repaying a portion of its bank term loan due in April 2011. Boston Scientific said it expects to record a pre-tax charge, not previously anticipated, of roughly $30 million (about $19 million after tax, or $0.01 a share) in the fourth quarter associated with the prepayment.

In other financing activity, Sirona Dental Systems (Long Island City, New York) reported the pricing of a previously disclosed public offering by Sirona Holdings Luxco of 7.1 million shares of common stock and 250,000 shares by Jeffrey Slovin, at a price to the public of $32.75 a share.

The offering is expected to close Wednesday subject to customary closing conditions. Sirona Dental Systems said it would not receive any proceeds from this sale of its common stock. One of the selling stockholders, Sirona Holdings Luxco, has also granted the underwriter a 30-day option to purchase up to 1,102,500 additional shares of common stock. Barclays Capital is the sole underwriter of the offering.